Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency
- 8 March 2000
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1464 (1) , 95-103
- https://doi.org/10.1016/s0005-2736(99)00250-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Polyethylenimine-based intravenous delivery of transgenes to mouse lungGene Therapy, 1998
- Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapyGene Therapy, 1998
- A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosisGene Therapy, 1997
- Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosisGene Therapy, 1997
- Systemic gene therapy: biodistribution and long-term expression of a transgene in mice.Proceedings of the National Academy of Sciences, 1995
- Cationic Phosphonolipids as non Viral Vectors for DNA TransfectionTetrahedron Letters, 1995
- Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosisNature Medicine, 1995
- Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.Proceedings of the National Academy of Sciences, 1993
- Systemic Gene Expression After Intravenous DNA Delivery into Adult MiceScience, 1993
- Localization of cystic fibrosis transmembrane conductance regulator mRNA in human fetal lung tissue by in situ hybridization.Journal of Clinical Investigation, 1992